Novel Lysine-specific Demethylase 1 Inhibitor as a Potential Therapeutics for Glioblastoma

被引：0
|
作者：
Shinjo, Keiko [1 ]
Murofushi, Yoshiteru [1 ]
Suzuki, Miho [1 ]
Kondo, Yutaka [1 ]
机构：
[1] Nagoya Uni Grad, Div Canc Biol, Sch Med, Nagoya, Aichi, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3168
引用
收藏
页码：2077 / 2077
页数：1
相关论文
共 50 条
  • [1] Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
    Shinjo, Keiko
    Umehara, Takashi
    Niwa, Hideaki
    Sato, Shin
    Katsushima, Keisuke
    Sato, Shinya
    Wang, Xingxing
    Murofushi, Yoshiteru
    Suzuki, Miho M.
    Koyama, Hiroo
    Kondo, Yutaka
    CANCER GENE THERAPY, 2024, 31 (12) : 1884 - 1894
  • [2] Lysine-specific demethylase 1 as a potential therapeutic target
    Stavropoulos, Pete
    Hoelz, Andre
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (06) : 809 - 820
  • [3] Divalent tranylcypromine derivative as lysine-specific demethylase 1 inhibitor
    Yin Sun
    Na Li
    Mingbo Su
    Xiaowen Wang
    Dongmei Zhao
    Bing Xiong
    Yubo Zhou
    Tongchao Liu
    Yue-Lei Chen
    Medicinal Chemistry Research, 2021, 30 : 421 - 428
  • [4] Divalent tranylcypromine derivative as lysine-specific demethylase 1 inhibitor
    Sun, Yin
    Li, Na
    Su, Mingbo
    Wang, Xiaowen
    Zhao, Dongmei
    Xiong, Bing
    Zhou, Yubo
    Liu, Tongchao
    Chen, Yue-Lei
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (02) : 421 - 428
  • [5] Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective
    Dai, Xing-Jie
    Liu, Ying
    Xiong, Xiao-Peng
    Xue, Lei-Peng
    Zheng, Yi-Chao
    Liu, Hong-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14197 - 14215
  • [6] Lysine-Specific Demethylase 1 in Energy Metabolism: A Novel Target for Obesity
    Wang, Dan
    Kuang, Yanling
    Zhang, Guolong
    Xiao, Kan
    Liu, Yulan
    JOURNAL OF NUTRITION, 2022, 152 (07): : 1611 - 1620
  • [7] Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics
    Baby, Stephin
    Shinde, Suchita Dattatray
    Kulkarni, Neeraj
    Sahu, Bichismita
    ACS CHEMICAL BIOLOGY, 2023, 18 (10) : 2144 - 2155
  • [8] Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles
    Stitzlein, Lea M.
    Gangadharan, Achintyan
    Walsh, Leslie M.
    Nam, Deokhwa
    Espejo, Alexsandra B.
    Singh, Melissa M.
    Patel, Kareena H.
    Lu, Yue
    Su, Xiaoping
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Singh, Sanjay
    Sulman, Erik
    Lang, Frederick F.
    Chandra, Joya
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [9] A SELECTIVE LYSINE-SPECIFIC DEMETHYLASE 1 INHIBITOR SUPPRESSES TESTICULAR TUMOR PROLIFERATION
    Etani, Toshiki
    Naiki, Taku
    Nozaki, Satoshi
    Nagai, Takashi
    Iida, Keitaro
    Ando, Ryosuke
    Kawai, Noriyasu
    Takahashi, Satoru
    Suzuki, Takayoshi
    Yasui, Takahiro
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1064 - E1065
  • [10] PROSTATE CANCER GROWTH IMPAIRMENT BY NCL1, A NOVEL SELECTIVE LYSINE-SPECIFIC DEMETHYLASE 1 INHIBITOR
    Etani, Toshiki
    Naiki, Taku
    Iida, Keitaroh
    Ando, Ryosuke
    Kobayashi, Daichi
    Yamada, Kenji
    Naruyama, Hiromichi
    Fukuta, Katsuhiro
    Kawai, Noriyasu
    Tozawa, Keiichi
    Kohri, Kenjiro
    JOURNAL OF UROLOGY, 2014, 191 (04): : E330 - E330
12345